-
The ninth atypical antipsychotic agent has been approved by the FDA. Asenapine is somewhat unique in the class with different receptor binding than risperidone and olanzapine.
-
Long known to open a few doors, cold hard cash may now bring down walls as well.
-
-
One of infection prevention's true originals â in every sense of the term â Eddie Hedrick, BS, MT(ASCP), CIC, currently is emerging infections coordinator at the Missouri Department of Health and Senior Services in Jefferson City.
-
A coalition of unions and occupational health and safety professionals has called on New York state health commissioner Richard F. Daines to withdraw the emergency regulation that requires all health care workers to receive flu vaccinations by Nov. 30.
-
In response to rumors about the safety of the 2009 H1N1 pandemic influenza A vaccine, federal public health officials have addressed the following myths and errors about the current situation:
-
How difficult is it going to be to get people vaccinated against H1N1 pandemic influenza A?
-
A witch's brew of apathy, fear, and misinformation about the H1N1 influenza A vaccine may cause considerable toil and trouble for clinicians responding to the first pandemic in four decades.
-
In this issue: Depression and pregnancy, new vaccine recommendations from the CDC, cortico-steroids and/or antivirals for Bell's palsy, rasagiline and Parkinson's disease, and FDA Actions.
-
It has been known for years that patients with chronic fatigue syndrome (CFS) have a defect in a major antiviral pathway, the 2-5A/RNase L pathway. The RNaseL produces non-specific viral cleavage and, thus, protects us from many viral infections (innate immunity).